AbbVie wants USITC to investigate Alvotech over Humira ‘theft’

21-12-2021

Alex Baldwin

AbbVie wants USITC to investigate Alvotech over Humira ‘theft’

Piotr Swat / Shutterstock.com

AbbVie seeks to block imports of Alvotech’s biosimilar Humira (adalimumab) into the US, claiming that the Icelandic company plundered former employees and used its trade secrets to develop the drug.


AbbVie, USITC, Section 337, biosimilar, Alvotech, Finnegan, Iceland, US

LSIPR